subject: UMLS:C0338204

subject_name: Herceptin


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Pleural effusion

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:53477739

object_name: Pleural Effusion, CTCAE


subject: PUBCHEM.COMPOUND:53477739

object_name: x-ray of chest: pleural effusion


subject: PUBCHEM.COMPOUND:53477739

object_name: Single Ventricle Defect


subject: PUBCHEM.COMPOUND:53477739

object_name: Single ventricle


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:168243

object_name: obesity


subject: CHEBI:168243

object_name: Obesity, CTCAE


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:9605

subject_name: Tirofiban

object_name: No-Reflow Phenomenon

tested_intervention: yes


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: Disorder of transplanted kidney


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:59204

subject_name: Carbetocin

object_name: Severe pre-eclampsia, postpartum condition or complication


subject: CHEBI:63610

subject_name: Misoprostol


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Fatty Liver


subject: CHEBI:35530

subject_name: beta-adrenergic antagonist

object_name: coronary artery disorder


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: CHEBI:35498

subject_name: diuretic


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: CHEBI:5383

subject_name: Glimepiride


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:16962

subject_name: Cortisone

object_name: Addison Disease


subject: CHEBI:229764

subject_name: Selinexor

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:229764

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:229764

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:229764

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:229764

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:229764

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:229764

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C1328727

object_name: unspecified adult solid tumor, protocol specific


subject: GTOPDB:12848

object_name: liver carcinoma


subject: UMLS:C5555591

subject_name: netrin-1 inhibitor NP137


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Gastroparesis due to diabetes mellitus


subject: PUBCHEM.COMPOUND:46783403

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:46783403

object_name: Crohn disease


subject: CHEBI:4856

subject_name: Esmolol

object_name: hypertension


subject: CHEBI:4856

object_name: Hypertension, CTCAE


subject: CHEBI:4856

object_name: heart disorder


subject: CHEBI:4856

object_name: aneurysm


subject: CHEBI:4856

object_name: cardiovascular surgery result: angina


subject: CHEBI:4856

object_name: Angina pectoris


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Light for dates


subject: PUBCHEM.COMPOUND:126456119

object_name: Immune Tolerance


subject: PUBCHEM.COMPOUND:126456119

object_name: Drug Tolerance


subject: PUBCHEM.COMPOUND:126456119

object_name: Safety Issues


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: PR:000009978


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UMLS:C0022942


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: UniProtKB:Q8TCD2


subject: UniProtKB:Q8TCD2


subject: PUBCHEM.COMPOUND:118987284

subject_name: Nexium

object_name: chronic pancreatitis


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEMBL.COMPOUND:CHEMBL5314366

subject_name: ESOMEPRAZOLE MAGNESIUM


subject: UMLS:C0939527

subject_name: Viokase 16


subject: CHEBI:81916

subject_name: Pancrelipase


subject: UNII:FQ3DRG0N5K


subject: UMLS:C1302030

subject_name: amylase / lipase / protease


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: stage, adult acute myeloid leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: PR:000014866

subject_name: sialic acid-binding Ig-like lectin 12

object_name: pancreatic tubular adenocarcinoma


subject: PR:000014866

object_name: pancreatic ductal adenocarcinoma


subject: PR:000000073

subject_name: Muellerian-inhibiting factor


subject: PR:000000073


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: asthma


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: UMLS:C4547427

subject_name: (18F)T807 compound

object_name: neurodegenerative disease


subject: CHEBI:230386

subject_name: Pimonidazole

object_name: pancreatic neoplasm


subject: CHEBI:230386

object_name: exocrine pancreatic carcinoma


subject: CHEBI:230386

object_name: malignant pancreatic neoplasm


subject: CHEBI:230386

object_name: Pancreas carcinoma resectable


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:31348

subject_name: Capecitabine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: Stage I Bladder Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage I Carcinoma of Bladder


subject: UMLS:C1882421

object_name: Stage II Bladder Cancer AJCC v6 and v7


subject: UMLS:C1882421

object_name: Stage II Bladder Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UMLS:C1882421

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C5237178

object_name: chronic kidney disease


subject: UMLS:C5237178

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Heartburn


subject: CHEBI:3723

subject_name: Citalopram


subject: UMLS:C3884632

object_name: end stage renal failure


subject: UMLS:C3884632

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: systemic inflammatory response syndrome


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UMLS:C3827154

object_name: neoplasm


subject: CHEBI:6121

subject_name: Ketamine

object_name: Vaso-Occlusive Crisis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Acute lymphoblastic leukemia, in relapse


subject: CHEBI:73604

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:73604

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:73604

object_name: Acute lymphoblastic leukemia with failed remission


subject: CHEBI:73604

object_name: Acute Lymphoblastic Leukemia not Having Achieved Remission


subject: CHEBI:231342

subject_name: ceralasertib

object_name: pediatric osteosarcoma


subject: CHEBI:231342

object_name: Osteosarcoma


subject: CHEBI:231342

object_name: Osteosarcoma recurrent


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: UMLS:C5201230

subject_name: Paclitaxel Liquid Injection

object_name: cervical cancer


subject: UMLS:C5201230

object_name: cervical carcinoma


subject: UMLS:C3854151

subject_name: Injection, paclitaxel, 1 mg administered


subject: UMLS:C3854151


subject: UMLS:C5854393

subject_name: Anti-PD-1 Monoclonal Antibody QL1604


subject: UMLS:C5854393


subject: CHEBI:60802

subject_name: ropivacaine

object_name: colorectal disorders


subject: UMLS:C0244231

subject_name: Diprospan

object_name: Autoimmunity


subject: CHEBI:31689

subject_name: Iguratimod


subject: CHEBI:6402

subject_name: Leflunomide


subject: CHEBI:8382

subject_name: Prednisone


subject: UMLS:C0718234

subject_name: Acthar

object_name: adult dermatomyositis


subject: UMLS:C0718234

object_name: dermatomyositis


subject: UMLS:C0718234

object_name: polymyositis


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Light for dates


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: pancreatic neoplasm


subject: CHEBI:49900

object_name: exocrine pancreatic carcinoma


subject: CHEBI:49900

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UMLS:C5446586

subject_name: P2RX3 Antagonist BAY 1817080

object_name: Cough


subject: UMLS:C5446586

object_name: Cough, CTCAE


subject: UMLS:C0027866

subject_name: Neuromuscular Blocking Agents

object_name: Mechanical ventilation finding


subject: CHEBI:3638

subject_name: Chloroquine


subject: CHEBI:3638


subject: CHEBI:3638


subject: UMLS:C3827056

object_name: colonic disease


subject: UMLS:C3896753

object_name: adult lymphoma


subject: UMLS:C3896753

object_name: lymphoma


subject: UMLS:C3896753

object_name: pediatric lymphoma


subject: UMLS:C3896753

object_name: mantle cell lymphoma


subject: UMLS:C3896753

object_name: B-cell neoplasm


subject: UMLS:C3896753

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3896753

object_name: non-Hodgkin lymphoma


subject: UMLS:C3896753

object_name: lymphoproliferative syndrome


subject: UMLS:C3896753

object_name: immunoproliferative disorder


subject: UMLS:C3896753

object_name: lymphoid system disorder


subject: UMLS:C3896753

object_name: Lymphadenopathy


subject: UMLS:C3896753

object_name: immune system disorder


subject: CHEMBL.COMPOUND:CHEMBL4297728

subject_name: CIRMTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEMBL.COMPOUND:CHEMBL4297728


subject: CHEBI:3207

subject_name: Budesonide

object_name: diarrhea


subject: CHEBI:3207

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:3207

object_name: Diarrhea, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: pervasive developmental disorder


subject: CHEBI:28939

object_name: autism spectrum disorder


subject: UNII:7CZ390V26X

subject_name: ENPATORAN

object_name: kidney failure


subject: DRUGBANK:DB16501

subject_name: Enpatoran


subject: CHEBI:63589

subject_name: Etravirine

object_name: HIV-1 infection


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Altered Level of Consciousness


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: MESH:C000722726

subject_name: RQ3013 COVID-19 vaccine


subject: GTOPDB:9195

subject_name: clazakizumab

object_name: Kidney transplant failure and rejection


subject: GTOPDB:9195

object_name: Disorder of transplanted kidney


subject: GTOPDB:9195

object_name: Transplant glomerulopathy


subject: GTOPDB:9195

object_name: chronic kidney disease


subject: GTOPDB:9195

object_name: Chronic uremia


subject: GTOPDB:9195

object_name: end stage renal failure


subject: UNII:4S38Z8RA9O


subject: UNII:4S38Z8RA9O


subject: UNII:4S38Z8RA9O


subject: UNII:4S38Z8RA9O


subject: UNII:4S38Z8RA9O


subject: UNII:4S38Z8RA9O


subject: UMLS:C2830049


subject: UMLS:C2830049


subject: UMLS:C2830049


subject: UMLS:C2830049


subject: UMLS:C2830049


subject: UMLS:C2830049


subject: UMLS:C2353377

object_name: influenza


subject: UMLS:C2353377

object_name: viral disease


subject: PUBCHEM.COMPOUND:118110201

object_name: Food-Drug Interactions


subject: UNII:DSP7A26K25


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: performance enhancing product use


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: CHEBI:91400

subject_name: Afatinib

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UMLS:C5197951

object_name: type 1 diabetes mellitus 1


subject: UMLS:C5197951

object_name: type 1 diabetes mellitus


subject: DRUGBANK:DB11286

subject_name: Colloidal oatmeal

object_name: Skin Bruise


subject: DRUGBANK:DB11286

object_name: Easy Bruising


subject: DRUGBANK:DB11286

object_name: Ecchymosis


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY


subject: CHEMBL.COMPOUND:CHEMBL2108391


subject: CHEMBL.COMPOUND:CHEMBL2108391


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:135905

subject_name: Terlipressin


subject: CHEBI:18357

subject_name: Norepinephrine

object_name: hepatorenal syndrome


subject: CHEBI:18357


subject: CHEBI:18357

object_name: liver cirrhosis


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Vomiting of pregnancy


subject: UMLS:C4330156

subject_name: HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C

object_name: cervical polyp


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: traumatic encephalopathy


subject: CHEBI:3160

object_name: traumatic brain injury


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Refractory Osteosarcoma


subject: UNII:M89N0Q7EQR

object_name: Osteosarcoma


subject: UNII:M89N0Q7EQR

object_name: bone sarcoma


subject: UNII:M89N0Q7EQR

object_name: bone giant cell tumor


subject: UNII:M89N0Q7EQR

object_name: Osteosarcoma recurrent


subject: UNII:M89N0Q7EQR

object_name: ovarian carcinosarcoma


subject: UNII:M89N0Q7EQR

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:M89N0Q7EQR

object_name: malignancy in giant cell tumor of bone


subject: UNII:M89N0Q7EQR

object_name: Recurrent ovarian cancer


subject: UNII:M89N0Q7EQR

object_name: thyroid gland squamous cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: UNII:M89N0Q7EQR

object_name: Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: UNII:M89N0Q7EQR

object_name: undifferentiated high grade pleomorphic sarcoma of bone


subject: UNII:M89N0Q7EQR

object_name: Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: UNII:M89N0Q7EQR

object_name: Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: UNII:M89N0Q7EQR

object_name: poorly differentiated thyroid gland carcinoma


subject: UNII:M89N0Q7EQR

object_name: dedifferentiated chondrosarcoma


subject: UNII:M89N0Q7EQR

object_name: Malignant Solid Neoplasm


subject: PR:000001379

object_name: Refractory Osteosarcoma


subject: PR:000001379

object_name: Osteosarcoma


subject: PR:000001379

object_name: bone sarcoma


subject: PR:000001379

object_name: bone giant cell tumor


subject: PR:000001379

object_name: Osteosarcoma recurrent


subject: PR:000001379

object_name: ovarian carcinosarcoma


subject: PR:000001379

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: PR:000001379

object_name: malignancy in giant cell tumor of bone


subject: PR:000001379

object_name: Recurrent ovarian cancer


subject: PR:000001379

object_name: thyroid gland squamous cell carcinoma


subject: PR:000001379

object_name: Platinum-Resistant Ovarian Carcinoma


subject: PR:000001379

object_name: Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: PR:000001379

object_name: Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: PR:000001379

object_name: undifferentiated high grade pleomorphic sarcoma of bone


subject: PR:000001379

object_name: Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: PR:000001379

object_name: Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: PR:000001379

object_name: poorly differentiated thyroid gland carcinoma


subject: PR:000001379

object_name: dedifferentiated chondrosarcoma


subject: PR:000001379

object_name: Malignant Solid Neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: bone sarcoma


subject: CHEBI:4026

object_name: bone giant cell tumor


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367

object_name: Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: sarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: Refractory Osteosarcoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Osteosarcoma recurrent


subject: PUBCHEM.COMPOUND:3367

object_name: ovarian carcinosarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: malignancy in giant cell tumor of bone


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:3367

object_name: thyroid gland squamous cell carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: PUBCHEM.COMPOUND:3367

object_name: Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: PUBCHEM.COMPOUND:3367

object_name: undifferentiated high grade pleomorphic sarcoma of bone


subject: PUBCHEM.COMPOUND:3367

object_name: Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: PUBCHEM.COMPOUND:3367

object_name: Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: PUBCHEM.COMPOUND:3367

object_name: poorly differentiated thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: dedifferentiated chondrosarcoma


subject: CHEBI:63599

subject_name: Fludarabine

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:63599

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:63599

object_name: sarcoma


subject: CHEBI:63599

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:63599

object_name: soft tissue sarcoma


subject: CHEBI:63599

object_name: bone sarcoma


subject: CHEBI:63599

object_name: bone giant cell tumor


subject: CHEBI:63599

object_name: ovarian carcinosarcoma


subject: CHEBI:63599

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:63599

object_name: malignancy in giant cell tumor of bone


subject: CHEBI:63599

object_name: Recurrent ovarian cancer


subject: CHEBI:63599

object_name: thyroid gland squamous cell carcinoma


subject: CHEBI:63599

object_name: Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:63599

object_name: Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:63599

object_name: undifferentiated high grade pleomorphic sarcoma of bone


subject: CHEBI:63599

object_name: Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:63599

object_name: Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:63599

object_name: poorly differentiated thyroid gland carcinoma


subject: CHEBI:63599

object_name: dedifferentiated chondrosarcoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:231679

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:231679

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:231679

object_name: soft tissue sarcoma


subject: CHEBI:231679

object_name: Refractory Osteosarcoma


subject: CHEBI:231679

object_name: bone sarcoma


subject: CHEBI:231679

object_name: bone giant cell tumor


subject: CHEBI:231679

object_name: Osteosarcoma recurrent


subject: CHEBI:231679

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:231679

object_name: malignancy in giant cell tumor of bone


subject: CHEBI:231679

object_name: thyroid gland squamous cell carcinoma


subject: CHEBI:231679

object_name: Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:231679

object_name: Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:231679

object_name: undifferentiated high grade pleomorphic sarcoma of bone


subject: CHEBI:231679

object_name: Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:231679

object_name: Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:231679

object_name: dedifferentiated chondrosarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C2346820

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C2346820

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C2346820

object_name: soft tissue sarcoma


subject: UMLS:C2346820

object_name: Refractory Osteosarcoma


subject: UMLS:C2346820

object_name: bone sarcoma


subject: UMLS:C2346820

object_name: bone giant cell tumor


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: hepatitis


subject: CHEBI:59902

object_name: Chronic hepatitis


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: Premature birth


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: carcinoma of esophagus


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C0071315

subject_name: Pneumovax

object_name: pneumococcal infection


subject: CHEBI:74073

subject_name: Ile-Met

object_name: influenza


subject: CHEBI:30366

subject_name: imidazolide


subject: UMLS:C1875300

subject_name: INTRAPLEURAL MEDICATIONS

object_name: pleural empyema


subject: UMLS:C1875300

object_name: Pleural effusion associated with pulmonary infection


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Distal Radius Fractures


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: PUBCHEM.COMPOUND:46174089

subject_name: GLUCOSAMINE SULFATE

object_name: Heberden node


subject: PUBCHEM.COMPOUND:46174089

object_name: osteoarthritis, hand


subject: CHEBI:28393

subject_name: D-glucosamine


subject: CHEBI:28393


subject: CHEBI:37878

subject_name: glucosamine sulfate


subject: CHEBI:37878


subject: CHEBI:20993

subject_name: GLUCOSAMINE


subject: CHEBI:20993


subject: UMLS:C5446634

subject_name: CD19-specific Adapter Molecule SWI019

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5446634

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C5446634

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5446634

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C5446634

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C5446634

object_name: Burkitt lymphoma


subject: UMLS:C5446634

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C5446634

object_name: Adult Burkitt Lymphoma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: heart failure


subject: CHEBI:119915

object_name: congestive heart failure


subject: CHEBI:119915

object_name: Dyspnea


subject: CHEBI:119915

object_name: Dyspnea, CTCAE


subject: CHEBI:119915

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: atrial fibrillation


subject: CHEBI:16347

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:16347

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: Small cell lung cancer extensive stage


subject: UMLS:C1258613

object_name: Small cell lung cancer recurrent


subject: UMLS:C4490367

subject_name: Nozin

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C4490367

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C4490367

object_name: Malignant Solid Neoplasm


subject: UMLS:C4490367

object_name: Solid Neoplasm


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Anorexia


subject: UNII:NQX9KB6PCL

object_name: eating disorder


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0384570


subject: UMLS:C0384570

object_name: osteoporosis


subject: UMLS:C0384570

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C0384570

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C0384570

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C0384570

object_name: Osteopenia


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: UMLS:C2825029


subject: UMLS:C2825029


subject: UMLS:C2825029


subject: UMLS:C2825029


subject: UMLS:C2825029


subject: CHEBI:6801

subject_name: Metformin

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:6801

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: stage IB pancreatic cancer


subject: CHEBI:6801

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:6801

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: stage IIB pancreatic cancer


subject: CHEBI:6801

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:6801

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:6801

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: stage IIA pancreatic cancer


subject: CHEBI:134745

subject_name: Glycerol phenylbutyrate

object_name: Parkinson disease


subject: UNII:386012Z45S

subject_name: Linerixibat

object_name: Pruritus, CTCAE


subject: UNII:386012Z45S

object_name: Pruritus


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: diarrhea


subject: UMLS:C3540708

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C3540708

object_name: Diarrhea, CTCAE


subject: UMLS:C3540708

object_name: colon adenocarcinoma


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Ureteric stone of lower third of ureter


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Hypovolemia


subject: CHEBI:119915

object_name: Physical trauma


subject: CHEBI:119915

object_name: Injury


subject: CHEBI:119915

object_name: Trauma


subject: CHEBI:30236

subject_name: difluorine


subject: CHEBI:30236

object_name: Acute Pain


subject: CHEBI:30236


subject: CHEBI:30236


subject: CHEBI:30236


subject: CHEBI:6843

subject_name: Methoxyflurane


subject: CHEBI:499361

subject_name: Aprepitant

object_name: non-small cell lung carcinoma


subject: UMLS:C2987611

subject_name: amatuximab

object_name: Mesothelin Positive


subject: UMLS:C2987611

object_name: cancer


subject: UMLS:C2987611

object_name: neoplasm


subject: UMLS:C5815593

object_name: Usher syndrome type 3


subject: UMLS:C5815593

object_name: Usher syndrome type 2


subject: UMLS:C5780032

subject_name: HUMAN CILIARY NEUROTROPHIC FACTOR


subject: UMLS:C5780032


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: digestive system infectious disorder


subject: CHEBI:51254

object_name: recurrent pneumonia


subject: CHEBI:51254

object_name: Skin and soft tissue infection


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UMLS:C0054066


subject: UMLS:C0054066


subject: CHEBI:53667

subject_name: Cefadroxil


subject: CHEBI:53667


subject: CHEBI:53667


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3504

subject_name: Cefpodoxime


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3534

subject_name: Cephalexin


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: CHEBI:100241


subject: UNII:6315412YVF

subject_name: Delafloxacin


subject: UNII:6315412YVF


subject: UNII:6315412YVF


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: UNII:6GNT3Y5LMF


subject: UNII:6GNT3Y5LMF


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63607

subject_name: Linezolid


subject: CHEBI:63607


subject: CHEBI:63607


subject: CHEBI:50885

subject_name: Fludrocortisone

object_name: borderline personality disorder


subject: CHEBI:169953

subject_name: Thr-Thr

object_name: stroke disorder


subject: CHEBI:169953

object_name: cerebrovascular disorder


subject: CHEBI:169953

object_name: Stroke (heart beat)


subject: CHEBI:169953

object_name: Stroke, CTCAE


subject: CHEBI:169953

object_name: Gait, Hemiplegic


subject: CHEBI:194146


subject: CHEBI:194146


subject: CHEBI:194146


subject: CHEBI:194146


subject: CHEBI:194146


subject: CHEBI:73662

subject_name: Thr-Pro


subject: CHEBI:73662


subject: CHEBI:73662


subject: CHEBI:73662


subject: CHEBI:73662


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: PR:000029585

subject_name: lamina-associated polypeptide 2


subject: PR:000029585


subject: PR:000029585


subject: PR:000029585


subject: PR:000029585


subject: PR:000009721


subject: PR:000009721


subject: PR:000009721


subject: PR:000009721


subject: PR:000009721


subject: PR:000016875

subject_name: thymidine phosphorylase


subject: PR:000016875


subject: PR:000016875


subject: PR:000016875


subject: PR:000016875


subject: UMLS:C5444129

subject_name: Latent Membrane Protein 2


subject: UMLS:C5444129


subject: UMLS:C5444129


subject: UMLS:C5444129


subject: UMLS:C5444129


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: Blepharokeratoconjunctivitis


subject: CHEBI:50848

subject_name: Loteprednol


subject: CHEBI:167574

subject_name: Semaglutide

object_name: kidney failure


subject: UMLS:C0718234

subject_name: Acthar

object_name: kidney disorder


subject: UMLS:C0718234

object_name: impaired renal function disease


subject: CHEBI:32133

object_name: acute respiratory distress syndrome


subject: CHEBI:32133

object_name: acute lung injury


subject: CHEBI:32133

object_name: systemic inflammatory response syndrome


subject: UMLS:C0879264

object_name: Fever


subject: UMLS:C0879264

object_name: Fever symptoms (finding)


subject: UMLS:C0879264

object_name: Fever, CTCAE


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin


subject: PUBCHEM.COMPOUND:78357831


subject: PUBCHEM.COMPOUND:78357831


subject: UMLS:C4725097

subject_name: Amblyomin-X

object_name: Advanced cancer


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: bacterial infectious disease


subject: UMLS:C0013227

object_name: pneumonia


subject: UMLS:C0013227

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C0013227

object_name: Sepsis


subject: UMLS:C0013227

object_name: Sepsis, CTCAE


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: CHEBI:35176

subject_name: Zinc sulfate


subject: CHEBI:35176


subject: CHEBI:35176


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Stomach cancer


subject: CHEBI:6456

object_name: gastric cancer


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C3853661

subject_name: Artificial Tears

object_name: dry eye syndrome


subject: UMLS:C3853661

object_name: Dry Eye, CTCAE


subject: UMLS:C3853661

object_name: Dryness of eye


subject: CHEBI:3641

subject_name: Chlorotrianisene

object_name: metaplastic cell transformation


subject: UMLS:C0723595

subject_name: Tace


subject: GTOPDB:13085

subject_name: adebrelimab


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: Fetal or neonatal effect of induction of labor


subject: CHEBI:8069

subject_name: Phenobarbital

object_name: Grand Mal Status Epilepticus


subject: CHEBI:8069

object_name: Generalized convulsive status epilepticus


subject: CHEBI:60654

subject_name: valproate


subject: CHEBI:60654


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEMBL.COMPOUND:CHEMBL4297858

subject_name: BUDIGALIMAB

object_name: liver carcinoma


subject: UMLS:C4527193


subject: GTOPDB:11762

subject_name: livmoniplimab


subject: UNII:42SH7JCD82

subject_name: LIVMONIPLIMAB


subject: UMLS:C5237368

subject_name: ARGX 115


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: carotid stenosis


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: UMLS:C3643658

subject_name: atorvastatin / ezetimibe


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Abnormal sperm morphology


subject: CHEBI:8884

subject_name: Rocuronium

object_name: strabismus


subject: CHEBI:8884

object_name: strabismus on exam (physical finding)


subject: CHEBI:8884

object_name: Regional anesthesia morbidity


subject: UNII:CD7WXM716P

object_name: Childhood Neuroblastoma


subject: UNII:CD7WXM716P

object_name: neuroblastoma


subject: UMLS:C1295507

subject_name: Bontoxilysin (substance)

object_name: mood (physical finding)


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: CHEBI:63633

subject_name: Triptorelin

object_name: precocious puberty


subject: CHEBI:63633

object_name: Precocious Puberty, CTCAE 5.0


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: dyspepsia


subject: UMLS:C1527137

object_name: Dyspepsia, CTCAE


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UNII:15ASW03C9S

subject_name: BALSALAZIDE DISODIUM

object_name: ulcerative colitis


subject: UNII:15ASW03C9S

object_name: inflammatory bowel disease 1


subject: UNII:15ASW03C9S

object_name: inflammatory bowel disease


subject: UMLS:C4548996

object_name: Alzheimer disease


subject: CHEBI:41423

subject_name: Celecoxib

object_name: ovarian neoplasm


subject: UMLS:C4725689

subject_name: EP4 Antagonist ONO-4578

object_name: Stomach cancer


subject: UMLS:C4725689

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Hypotonia


subject: CHEBI:64366

subject_name: isodesmosine

object_name: chronic hepatitis B virus infection


subject: CHEBI:64366

object_name: hepatitis B


subject: MESH:D007166

subject_name: Immunosuppressive Agents

object_name: euthyroid Graves orbitopathy


subject: MESH:D007166

object_name: endocrine exophthalmos


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Blasts 5 Percent or More of Bone Marrow Nucleated Cells


subject: PUBCHEM.COMPOUND:596

object_name: Philadelphia Chromosome Positive


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: UMLS:C3640822

object_name: Refractory acute myeloid leukemia


subject: UMLS:C3640822

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C3640822

object_name: Acute lymphoblastic leukemia recurrent


subject: UMLS:C3640822

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C3640822

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C3640822

object_name: Infant T Acute Lymphoblastic Leukemia


subject: UMLS:C3640822

object_name: Pre T-ALL


subject: UMLS:C3640822

object_name: T-cell childhood acute lymphocytic leukemia


subject: UMLS:C3640822

object_name: T-cell adult acute lymphocytic leukemia


subject: UMLS:C3640822

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C3640822


subject: UMLS:C3640822

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UMLS:C3640822


subject: UMLS:C3640822


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: Hodgkin Disease


subject: UMLS:C0279328

object_name: acute myeloid leukemia


subject: UMLS:C0279328

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0279328

object_name: non-Hodgkin lymphoma


subject: UMLS:C0279328

object_name: Lymphoma, Large-Cell, Follicular


subject: UMLS:C0279328

object_name: acute lymphoblastic leukemia


subject: UMLS:C0279328

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: UMLS:C0279328

object_name: Myelodysplasia


subject: UMLS:C0279328

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0279328

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0279328

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5882238

object_name: prostate carcinoma


subject: UMLS:C5882238

object_name: prostate cancer


subject: UMLS:C5882238

object_name: prostate adenocarcinoma


subject: UMLS:C5882238

object_name: liver carcinoma


subject: UMLS:C5882238

object_name: glioma


subject: UMLS:C5882238

object_name: malignant glioma


subject: UNII:3934EF02T7

subject_name: Piflufolastat F 18


subject: UNII:3934EF02T7


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Chronic Disease


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: GTOPDB:10609

subject_name: mezagitamab

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL4297833

subject_name: MEZAGITAMAB


subject: UMLS:C4688355

subject_name: Mezagitamab


subject: CHEBI:65209

subject_name: Lucitanib

object_name: Advanced cancer


subject: CHEBI:31399

subject_name: Cilnidipine

object_name: stroke disorder


subject: CHEBI:31399

object_name: cerebrovascular disorder


subject: CHEBI:31399

object_name: Stroke (heart beat)


subject: CHEBI:31399

object_name: Stroke, CTCAE


subject: CHEBI:31399

object_name: hypertension


subject: CHEBI:31399

object_name: Hypertension, CTCAE


subject: UNII:B0L24T8TB7

object_name: esophageal adenocarcinoma


subject: UNII:B0L24T8TB7

object_name: lung adenocarcinoma


subject: UNII:B0L24T8TB7

object_name: cervical adenocarcinoma


subject: UNII:B0L24T8TB7

object_name: adenocarcinoma


subject: UNII:B0L24T8TB7

object_name: bile duct adenocarcinoma


subject: UNII:B0L24T8TB7

object_name: gastric adenocarcinoma


subject: UNII:B0L24T8TB7

object_name: Colon Neoplasm


subject: UNII:B0L24T8TB7

object_name: neoplasm


subject: UMLS:C0591320

subject_name: Cytosar

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Locally Advanced Esophageal Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Esophageal adenocarcinoma stage IV


subject: PUBCHEM.COMPOUND:14907381

object_name: Unresectable Esophageal Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IV Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:191174

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:191174

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:191174


subject: CHEBI:191174

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage II Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:191174


subject: CHEBI:191174

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: keloid


subject: CHEBI:135173

subject_name: Taurolidine

object_name: Catheter related infection


subject: CHEBI:74947

subject_name: Thalidomide

object_name: interstitial lung disease 1


subject: CHEBI:74947

object_name: Cough


subject: CHEBI:74947

object_name: Cough, CTCAE


subject: PUBCHEM.COMPOUND:14907381

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:14907381

object_name: advanced adult primary liver cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIC Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIC Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: malignant large intestine neoplasm stage IIIb


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IVA gallbladder cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Adenocarcinoma of Unknown Primary


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IIIA gallbladder cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: metastatic extrahepatic bile duct cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: gallbladder adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: cancer of unknown primary site


subject: PUBCHEM.COMPOUND:14907381

object_name: cholangiocarcinoma of the gallbladder


subject: PUBCHEM.COMPOUND:14907381

object_name: newly diagnosed carcinoma of unknown primary


subject: PUBCHEM.COMPOUND:14907381

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:46345

object_name: advanced adult primary liver cancer


subject: CHEBI:46345

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:46345

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:46345

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:46345

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:46345

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:46345

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:46345

object_name: stage IVA gallbladder cancer


subject: CHEBI:46345

object_name: Adenocarcinoma of Unknown Primary


subject: CHEBI:46345

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:46345

object_name: stage IIIA gallbladder cancer


subject: CHEBI:46345

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:46345

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:46345

object_name: metastatic extrahepatic bile duct cancer


subject: CHEBI:46345

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:46345

object_name: gallbladder adenocarcinoma


subject: CHEBI:46345

object_name: cancer of unknown primary site


subject: CHEBI:46345

object_name: cholangiocarcinoma of the gallbladder


subject: CHEBI:46345

object_name: newly diagnosed carcinoma of unknown primary


subject: CHEBI:46345

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:46345

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:90881

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: stage IV pancreatic cancer


subject: CHEBI:90881

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:90881

object_name: stage IIIA rectal cancer


subject: CHEBI:90881

object_name: advanced adult primary liver cancer


subject: CHEBI:90881

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:90881

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:90881

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:90881

object_name: stage IVA gallbladder cancer


subject: CHEBI:90881

object_name: Adenocarcinoma of Unknown Primary


subject: CHEBI:90881

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:90881

object_name: stage IIIA gallbladder cancer


subject: CHEBI:90881

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: metastatic extrahepatic bile duct cancer


subject: CHEBI:90881

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:90881

object_name: gastric intestinal type adenocarcinoma


subject: CHEBI:90881

object_name: gallbladder adenocarcinoma


subject: CHEBI:90881

object_name: cancer of unknown primary site


subject: CHEBI:90881

object_name: Gastric Mixed Adenocarcinoma


subject: CHEBI:90881

object_name: diffuse gastric adenocarcinoma


subject: CHEBI:90881

object_name: cholangiocarcinoma of the gallbladder


subject: CHEBI:90881

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:90881

object_name: newly diagnosed carcinoma of unknown primary


subject: CHEBI:90881

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:90881

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:90881

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IIIB Gastric Carcinoma


subject: CHEBI:90881

object_name: Stage IIIA Gastric Carcinoma


subject: CHEBI:90881

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:90881

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:90881

object_name: cholangiocarcinoma


subject: CHEBI:8988

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: stage IV pancreatic cancer


subject: CHEBI:8988

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:8988

object_name: stage IIIA rectal cancer


subject: CHEBI:8988

object_name: advanced adult primary liver cancer


subject: CHEBI:8988

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:8988

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:8988

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:8988

object_name: stage IVA gallbladder cancer


subject: CHEBI:8988

object_name: Adenocarcinoma of Unknown Primary


subject: CHEBI:8988

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:8988

object_name: stage IIIA gallbladder cancer


subject: CHEBI:8988

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:8988

object_name: metastatic extrahepatic bile duct cancer


subject: CHEBI:8988

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:8988

object_name: gallbladder adenocarcinoma


subject: CHEBI:8988

object_name: cholangiocarcinoma of the gallbladder


subject: CHEBI:8988

object_name: newly diagnosed carcinoma of unknown primary


subject: CHEBI:8988

object_name: Stage IIIA Gastric Carcinoma


subject: CHEBI:8988

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:8988

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:80630

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:80630

object_name: stage IIIA rectal cancer


subject: CHEBI:80630

object_name: advanced adult primary liver cancer


subject: CHEBI:80630

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:80630

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:80630

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:80630

object_name: stage IVA gallbladder cancer


subject: CHEBI:80630

object_name: Adenocarcinoma of Unknown Primary


subject: CHEBI:80630

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:80630

object_name: stage IIIA gallbladder cancer


subject: CHEBI:80630

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:80630

object_name: metastatic extrahepatic bile duct cancer


subject: CHEBI:80630

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:80630

object_name: gallbladder adenocarcinoma


subject: CHEBI:80630

object_name: cholangiocarcinoma of the gallbladder


subject: CHEBI:80630

object_name: newly diagnosed carcinoma of unknown primary


subject: CHEBI:80630

object_name: Stage IIIA Gastric Carcinoma


subject: CHEBI:80630

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:80630

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:15640

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:15640

object_name: stage IV pancreatic cancer


subject: CHEBI:15640

object_name: advanced adult primary liver cancer


subject: CHEBI:15640

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:15640

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:15640

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:15640

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:15640

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:15640

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:15640

object_name: stage IVA gallbladder cancer


subject: CHEBI:15640

object_name: Adenocarcinoma of Unknown Primary


subject: CHEBI:15640

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:15640

object_name: stage IIIA gallbladder cancer


subject: CHEBI:15640

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:15640

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:15640

object_name: metastatic extrahepatic bile duct cancer


subject: CHEBI:15640

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:15640

object_name: gallbladder adenocarcinoma


subject: CHEBI:15640

object_name: cancer of unknown primary site


subject: CHEBI:15640

object_name: cholangiocarcinoma of the gallbladder


subject: CHEBI:15640

object_name: newly diagnosed carcinoma of unknown primary


subject: CHEBI:15640

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:15640

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: PUBCHEM.COMPOUND:43805

object_name: advanced adult primary liver cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: malignant large intestine neoplasm stage IIIb


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: stage IVA gallbladder cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Adenocarcinoma of Unknown Primary


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: stage IIIA gallbladder cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: metastatic extrahepatic bile duct cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: gallbladder adenocarcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: cancer of unknown primary site


subject: PUBCHEM.COMPOUND:43805

object_name: cholangiocarcinoma of the gallbladder


subject: PUBCHEM.COMPOUND:43805

object_name: newly diagnosed carcinoma of unknown primary


subject: PUBCHEM.COMPOUND:43805

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: UMLS:C1314429

object_name: advanced adult primary liver cancer


subject: UMLS:C1314429

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UMLS:C1314429

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UMLS:C1314429

object_name: malignant large intestine neoplasm stage IIIb


subject: UMLS:C1314429

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UMLS:C1314429

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: UMLS:C1314429

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: UMLS:C1314429

object_name: stage IVA gallbladder cancer


subject: UMLS:C1314429

object_name: Adenocarcinoma of Unknown Primary


subject: UMLS:C1314429

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: UMLS:C1314429

object_name: stage IIIA gallbladder cancer


subject: UMLS:C1314429

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: UMLS:C1314429

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: UMLS:C1314429

object_name: metastatic extrahepatic bile duct cancer


subject: UMLS:C1314429

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UMLS:C1314429

object_name: gallbladder adenocarcinoma


subject: UMLS:C1314429

object_name: cancer of unknown primary site


subject: UMLS:C1314429

object_name: cholangiocarcinoma of the gallbladder


subject: UMLS:C1314429

object_name: newly diagnosed carcinoma of unknown primary


subject: UMLS:C1314429

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UMLS:C1314429

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: UNII:T60AV22R32

subject_name: Chlorazine


subject: CHEBI:3647

subject_name: Chlorpromazine


subject: CHEBI:4911

subject_name: Etoposide

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:4911

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:4911

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:4911

object_name: stage IIB non-small cell lung cancer


subject: CHEBI:4911

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:4911

object_name: stage IIA non-small cell lung cancer


subject: CHEBI:4911

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: marginal zone lymphoma


subject: CHEBI:73604

object_name: MALT lymphoma


subject: CHEBI:95341

subject_name: Baricitinib

object_name: generalized vitiligo


subject: UMLS:C3495458

subject_name: antibodies (medication)

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C3495458

object_name: Myelodysplasia


subject: UMLS:C3495458

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C3495458

object_name: childhood myelodysplastic syndrome


subject: UMLS:C3495458

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C3495458

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C3495458

object_name: acute lymphoblastic leukemia


subject: UMLS:C3495458

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C3495458

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3495458

object_name: acute myeloid leukemia


subject: UMLS:C3495458

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3495458

object_name: non-Hodgkin lymphoma


subject: UMLS:C3495458

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C3495458

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3495458

object_name: Hodgkin Disease


subject: UMLS:C3495458

object_name: leukemia


subject: UMLS:C3495458

object_name: childhood leukemia


subject: UMLS:C0813154

subject_name: Antibodies, in vitro diagnostic

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C0813154

object_name: Myelodysplasia


subject: UMLS:C0813154

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0813154

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0813154

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0813154

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C0813154

object_name: acute lymphoblastic leukemia


subject: UMLS:C0813154

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0813154

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0813154

object_name: acute myeloid leukemia


subject: UMLS:C0813154

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0813154

object_name: non-Hodgkin lymphoma


subject: UMLS:C0813154

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C0813154

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0813154

object_name: Hodgkin Disease


subject: UMLS:C0813154

object_name: leukemia


subject: UMLS:C0813154

object_name: childhood leukemia


subject: UMLS:C0003241

subject_name: Antibodies

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C0003241

object_name: Myelodysplasia


subject: UMLS:C0003241

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0003241

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0003241

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0003241

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C0003241

object_name: acute lymphoblastic leukemia


subject: UMLS:C0003241

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0003241

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0003241

object_name: acute myeloid leukemia


subject: UMLS:C0003241

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0003241

object_name: non-Hodgkin lymphoma


subject: UMLS:C0003241

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C0003241

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0003241

object_name: Hodgkin Disease


subject: UMLS:C0003241

object_name: leukemia


subject: UMLS:C0003241

object_name: childhood leukemia


subject: GTOPDB:8966

subject_name: onartuzumab

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743051

subject_name: ONARTUZUMAB


subject: UMLS:C2826110


subject: UNII:TA63JX8X52

subject_name: Mericitabine

object_name: hepatitis C


subject: CHEBI:22587

subject_name: antiviral agent


subject: UMLS:C0003451

subject_name: Antiviral Agents


subject: UMLS:C5551438

subject_name: Antiviral [EPC]


subject: CHEBI:3374

subject_name: Capsaicin

object_name: cerebrovascular disorder


subject: UMLS:C3896849

object_name: plasma cell myeloma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R

object_name: marginal zone lymphoma


subject: UNII:U2I8T43Y7R

object_name: MALT lymphoma


subject: CHEBI:32139


subject: UMLS:C5966113

subject_name: CDK8/19 Inhibitor RVU120

object_name: myelofibrosis


subject: CHEBI:76567

subject_name: polyunsaturated fatty acid anion

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:76567

object_name: metabolic syndrome X


subject: CHEBI:76567

object_name: hypertension


subject: CHEBI:76567

object_name: Hypertension, CTCAE


subject: CHEBI:76567

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0032615

subject_name: Polyunsaturated Fatty Acids


subject: UMLS:C0032615


subject: UMLS:C0032615


subject: UMLS:C0032615


subject: UMLS:C0032615


subject: CHEBI:26208

subject_name: polyunsaturated fatty acid


subject: CHEBI:26208


subject: CHEBI:26208


subject: CHEBI:26208


subject: CHEBI:26208


subject: PUBCHEM.COMPOUND:284240

object_name: HIV infection


subject: CHEBI:177762

subject_name: Alovudine


subject: UMLS:C1450911

subject_name: TCH 346

object_name: Parkinson disease


subject: UMLS:C2987611

subject_name: amatuximab

object_name: malignant pleural mesothelioma


subject: GTOPDB:7750


subject: UNII:6HP0354G04


subject: CHEBI:231651

subject_name: Vosaroxin

object_name: small cell lung carcinoma


subject: CHEBI:231651

object_name: small cell carcinoma


subject: UMLS:C1541378


subject: UMLS:C1541378


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:22652

object_name: stage IV pancreatic cancer


subject: CHEBI:22652

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: Cytokine Release Syndrome, CTCAE


subject: UNII:T4H8FMA7IM

object_name: Plasma cell myeloma refractory


subject: UNII:T4H8FMA7IM

object_name: cell-associated neurotoxicity


subject: UNII:54534MX6Z9

subject_name: Teclistamab

object_name: cytokine release syndrome


subject: UNII:54534MX6Z9


subject: UNII:54534MX6Z9


subject: UMLS:C4527013


subject: UMLS:C4527013


subject: UMLS:C4527013


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Osteopenia/osteoporosis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:57377410

subject_name: GEMLAPODECT

object_name: Tourette syndrome


subject: UNII:RF3JGD64ZU


subject: UMLS:C5391556

object_name: Adult Meningioma


subject: UMLS:C5391556

object_name: benign meningioma


subject: UMLS:C5391556

object_name: familial meningioma


subject: UMLS:C5391556

object_name: pediatric meningioma


subject: UMLS:C5391556

object_name: meningioma


subject: UMLS:C5419110

subject_name: Cu-67 sartate


subject: UMLS:C5419110


subject: UMLS:C5419110


subject: UMLS:C5419110


subject: UMLS:C5419110


subject: CHEBI:4672

subject_name: Docetaxel

object_name: superficial urinary bladder carcinoma


subject: CHEBI:4672

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score A


subject: CHEBI:4672

object_name: International Prognostic Index Low Risk Group


subject: CHEBI:4672

object_name: Low risk


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:25357

subject_name: mitomycin


subject: CHEBI:25357

object_name: bladder tumor


subject: CHEBI:25357

object_name: urinary bladder carcinoma


subject: CHEBI:25357

object_name: urinary bladder cancer


subject: CHEBI:25357

object_name: childhood bladder carcinoma


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: ureter cancer


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: ureter carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: carcinoma of urethra


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: urethra cancer


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: renal pelvis carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: malignant renal pelvis neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: bladder transitional cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: transitional cell carcinoma


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:175901


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: HIV-1 infection


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: temporal arteritis


subject: UMLS:C0378942


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: trichuriasis


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Sepsis


subject: CHEBI:8378

object_name: Sepsis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3545318

subject_name: REXLEMESTROCEL-L

object_name: intervertebral disk degenerative disorder


subject: CHEMBL.COMPOUND:CHEMBL3545318

object_name: lumbar disk degenerative disorder


subject: UNII:6K6L7E3F1L

subject_name: Gefapixant

object_name: Chronic cough


subject: UMLS:C0393062

subject_name: Dendritic Cell-MART-1 Peptide Vaccine

object_name: melanoma


subject: PUBCHEM.COMPOUND:3085828

subject_name: Gadoteric acid

object_name: Adverse drug response


subject: CHEBI:5441

subject_name: Glyburide

object_name: type 1 diabetes mellitus 1


subject: CHEBI:5441

object_name: type 1 diabetes mellitus


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: metastatic melanoma


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Fractured ankle


subject: CHEBI:15379

subject_name: Oxygen


subject: UMLS:C0935868

subject_name: paclitaxel liposome

object_name: carcinoma of esophagus


subject: CHEBI:31898

subject_name: Nedaplatin


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Prostate cancer recurrent


subject: CHEBI:63584

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:68534

subject_name: Enzalutamide


subject: GTOPDB:10656

subject_name: ianalumab

object_name: lupus nephritis


subject: UNII:ZN2GQ3II96


subject: UMLS:C3896750


subject: CHEBI:63631

subject_name: Topiramate

object_name: childhood absence epilepsy


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: OPTN-related open angle glaucoma


subject: PUBCHEM.COMPOUND:14907381

object_name: open-angle glaucoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: GTOPDB:6749

subject_name: fibrinogen

object_name: Contusions


subject: GTOPDB:6749

object_name: reported bruising (history)


subject: GTOPDB:6749

object_name: Bruising, CTCAE


subject: KEGG.COMPOUND:C00393

subject_name: Fibrinogen


subject: KEGG.COMPOUND:C00393


subject: KEGG.COMPOUND:C00393


subject: UMLS:C3540039

subject_name: Fibrinogen containing hemostatics


subject: UMLS:C3540039


subject: UMLS:C3540039


subject: UMLS:C2587184

subject_name: Parenogen


subject: UMLS:C2587184


subject: UMLS:C2587184


subject: UMLS:C0016006


subject: UMLS:C0016006


subject: UMLS:C0016006


subject: CHEBI:5931

subject_name: insulin human

object_name: Type 1 diabetes mellitus with hypoglycemia


subject: UMLS:C0123677

subject_name: NovoLog


subject: CHEBI:135342

subject_name: Reboxetine

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:135342

object_name: Fatigue


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Postoperative Complications


subject: CHEBI:8378

object_name: eye infection


subject: CHEBI:73678


subject: CHEBI:73678


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:28864


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: Post-partum hemorrhage


subject: UNII:W0UTB622GK

object_name: alcohol abuse


subject: UNII:W0UTB622GK

object_name: alcohol dependence


subject: CHEBI:50692

subject_name: Mifepristone

object_name: central serous chorioretinopathy


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: anterior uveitis


subject: CHEBI:167308

subject_name: Dextromethadone


subject: CHEBI:66964

subject_name: Dronabinol

object_name: DRUG ABUSE MEDICATION


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C1704263

subject_name: green tea extract

object_name: unspecified adult solid tumor, protocol specific


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: CHEBI:36796

subject_name: duloxetine

object_name: PELVIS PAIN CHRONIC


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: hypertension, pregnancy-induced


subject: DRUGBANK:DB10640

object_name: preeclampsia


subject: CHEBI:95165

object_name: melanoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:27470

subject_name: Folic acid

object_name: pervasive developmental disorder


subject: CHEBI:27470

object_name: autism


subject: CHEBI:49960

subject_name: Vandetanib

object_name: Stomach cancer


subject: CHEBI:49960

object_name: gastric cancer


subject: CHEBI:135515

subject_name: Bendamustine

object_name: lymphoblastic lymphoma


subject: CHEBI:135515

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:135515

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:135515

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:135515

object_name: lymphoblastic leukemia, acute, with lymphomatous features


subject: CHEBI:135515

object_name: acute biphenotypic leukemia


subject: CHEBI:135515

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: UMLS:C5848188

subject_name: tacrolimus 5 MG Oral Capsule includes BX Rating

object_name: acute lymphoblastic leukemia


subject: UMLS:C5848188


subject: UMLS:C5848188


subject: UMLS:C5848188


subject: UMLS:C5848188

object_name: acute myeloid leukemia


subject: UMLS:C5848188


subject: UMLS:C5848188


subject: UMLS:C5848188


subject: UMLS:C5848188


subject: UMLS:C5848188

object_name: Myelodysplasia


subject: UMLS:C5848188

object_name: myeloproliferative neoplasm


subject: UMLS:C5848188

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:50217

subject_name: selegiline

object_name: amphetamine abuse


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: heart disorder


subject: UMLS:C0982327

subject_name: PEGINTERFERON

object_name: plasma cell myeloma


subject: UMLS:C1448439

subject_name: Atenativ

object_name: hereditary antithrombin deficiency


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UMLS:C4287697


subject: UMLS:C4085977

subject_name: Anti-OX40 Monoclonal Antibody GSK3174998


subject: CHEBI:135942

subject_name: Laropiprant

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: PUBCHEM.COMPOUND:284240

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:284240

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: vaginal cancer


subject: PUBCHEM.COMPOUND:284240

object_name: vaginal carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:284240

object_name: tumor of uterus


subject: PUBCHEM.COMPOUND:284240

object_name: vulva carcinoma


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UMLS:C0962969

subject_name: RAD 001

object_name: NF2-related schwannomatosis


subject: UMLS:C0962969

object_name: vestibular schwannomatosis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Peripheral neuralgia


subject: CHEBI:60654

subject_name: valproate

object_name: epilepsy


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE

object_name: bipolar disorder


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: endogenous depression


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: major depressive disorder


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: PUBCHEM.COMPOUND:122677428

object_name: Rhegmatogenous retinal detachment - macula off


subject: UMLS:C5544747


subject: UMLS:C3896677

subject_name: Electrokinetically Modified Water

object_name: Muscle damage


subject: CHEBI:137254

subject_name: Glu-Met-Trp


subject: UniProtKB:P04993

subject_name: RECD_ECOLI RecBCD enzyme subunit RecD (sprot)

object_name: cancer


subject: UniProtKB:P04993

object_name: neoplasm


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: GTOPDB:11607

subject_name: barzolvolimab

object_name: dermatographia


subject: GTOPDB:11607

object_name: cold urticaria


subject: GTOPDB:11607

object_name: chronic inducible urticaria


subject: UNII:4B77GX0NA3

subject_name: BARZOLVOLIMAB


subject: UNII:4B77GX0NA3


subject: UNII:4B77GX0NA3


subject: UMLS:C5669595

subject_name: Barzolvolimab


subject: UMLS:C5669595


subject: UMLS:C5669595


subject: UMLS:C0907160

subject_name: Pegylated Interferon Alfa

object_name: skin melanoma


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Shoulder pain


subject: CHEBI:144903

object_name: spinal cord injury


subject: CHEBI:144903

object_name: Rotator Cuff Tendinitis


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: UNII:ZU3D90W5GZ

subject_name: lactisole

object_name: Hunger


subject: UNII:ZU3D90W5GZ

object_name: hypoglycemia


subject: CHEBI:173971

subject_name: LACTISOLE


subject: CHEBI:173971


subject: CHEBI:145019

subject_name: rebaudioside M


subject: CHEBI:145019


subject: CHEBI:7478

subject_name: Naratriptan

object_name: Headache


subject: CHEBI:7478

object_name: Headache, CTCAE


subject: CHEBI:59527


subject: CHEBI:59527


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: UMLS:C4329319

subject_name: Anti-CSF1 Monoclonal Antibody PD-0360324

object_name: pulmonary sarcoidosis


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: Multiple sclerosis relapse


subject: UMLS:C1541395


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Cholestasis of parenteral nutrition


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Transformed migraine


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: squamous cell carcinoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: UMLS:C0732850

subject_name: Propess

object_name: Labor Pain


subject: CHEBI:15551

subject_name: Dinoprostone


subject: UMLS:C0699579

subject_name: Prostin E2


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Neck Carcinoma


subject: GTOPDB:7988

object_name: head and neck neoplasm


subject: GTOPDB:7988

object_name: head and neck cancer


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: Cannabis use


subject: CHEBI:194533

subject_name: nihonium atom

object_name: influenza


subject: CHEBI:29339

subject_name: Nitrene


subject: CHEBI:73424

subject_name: Asn-His


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation

object_name: Overlap syndrome


subject: UMLS:C0350411

object_name: obstructive sleep apnea syndrome


subject: UMLS:C0350411

object_name: chronic obstructive pulmonary disease


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Heartburn


subject: UMLS:C4727551

subject_name: Colorectal Cancer Peptide Vaccine PolyPEPI1018

object_name: metastatic colorectal cancer


subject: CHEBI:76842

object_name: peanut allergy


subject: CHEBI:28001

subject_name: Vancomycin


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: intestinal disorder


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: chronic kidney disease


subject: UNII:4EQZ6YO2HI

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: conduct disorder


subject: CHEBI:134716

object_name: bipolar I disorder


subject: CHEBI:134716

object_name: oppositional defiant disorder


subject: CHEBI:134716

object_name: pervasive developmental disorder


subject: CHEBI:134716

object_name: autism


subject: CHEBI:134716

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:134716


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Tabagism


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Neonatal cardiac arrest


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UNII:0C1JUU9S0L

object_name: Myelodysplasia


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: hypertension


subject: CHEBI:73629

object_name: Hypertension, CTCAE


subject: CHEBI:38848

subject_name: perflunafene


subject: CHEBI:38848


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: PR:000001881


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: lung superior sulcus carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IIB Lung Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: RXCUI:2283226

subject_name: bempedoic acid / ezetimibe Oral Product

object_name: coronary artery disorder


subject: RXCUI:2283226

object_name: coronary atherosclerosis


subject: RXCUI:2283226

object_name: arteriosclerosis disorder


subject: RXCUI:2283226

object_name: atherosclerosis


subject: RXCUI:2283226

object_name: myocardial infarction


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester


subject: PUBCHEM.COMPOUND:3298


subject: PUBCHEM.COMPOUND:3298


subject: PUBCHEM.COMPOUND:3298


subject: PUBCHEM.COMPOUND:3298


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:84883


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: PUBCHEM.COMPOUND:73151030


subject: PUBCHEM.COMPOUND:73151030


subject: GTOPDB:13624

subject_name: inclisiran


subject: GTOPDB:13624


subject: GTOPDB:13624


subject: CHEBI:7852

subject_name: Oxycodone

object_name: mitral valve disorder


subject: CHEBI:7852

object_name: Mitral Valve Disease, CTCAE


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: PR:000008826

subject_name: basement membrane-specific heparan sulfate proteoglycan core protein

object_name: Psychomotor Retardation


subject: UMLS:C0031669

subject_name: Phospholipase C


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: UMLS:C0392938

subject_name: zoledronate


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C5198279

subject_name: AMG 557

object_name: Primary Sjögren's syndrome


subject: CHEBI:3219

subject_name: Bupropion

object_name: Suicidal ideation


subject: CHEBI:3219

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:6367

subject_name: Lamotrigine


subject: CHEBI:6367


subject: CHEBI:3139

subject_name: bleomycin

object_name: vascular malformation


subject: PR:000008905

subject_name: gamma-interferon-inducible lysosomal thiol reductase

object_name: acute myeloid leukemia


subject: CHEBI:60775

subject_name: Verteporfin

object_name: Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: UNII:LA88IH4O02

subject_name: Mezigdomide

object_name: kidney failure


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: pancreatic neoplasm


subject: CHEBI:229221

object_name: exocrine pancreatic carcinoma


subject: CHEBI:229221

object_name: malignant pancreatic neoplasm


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: UMLS:C5207052


subject: UMLS:C5207052


subject: UNII:FOF5155FMZ

object_name: Childhood Breast Carcinoma


subject: UNII:FOF5155FMZ

object_name: breast carcinoma


subject: UNII:FOF5155FMZ

object_name: breast cancer


subject: UNII:FOF5155FMZ

object_name: nonpapillary renal cell carcinoma


subject: UNII:FOF5155FMZ

object_name: clear cell renal carcinoma


subject: UNII:FOF5155FMZ

object_name: renal cell adenocarcinoma


subject: UNII:FOF5155FMZ

object_name: renal cell carcinoma


subject: UMLS:C5446299

subject_name: Eganelisib


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: CHEBI:7465

subject_name: Naltrexone

object_name: intellectual disability


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Uterine hemorrhage


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan


subject: UNII:3XPI7EG4W8


subject: UNII:3XPI7EG4W8


subject: UNII:3XPI7EG4W8

object_name: breast neoplasm


subject: UMLS:C4527158


subject: UMLS:C4527158


subject: UMLS:C4527158


subject: UMLS:C4527158


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:18772499

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: CHEBI:70714

subject_name: Teflaro

object_name: Community-Acquired Pneumonia


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Shoulder pain


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: focal segmental glomerulosclerosis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: HMDB:HMDB0259623

subject_name: Egrifta

object_name: lipodystrophy


subject: PUBCHEM.COMPOUND:45382195

subject_name: Thymosin Beta 4

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:45382195

object_name: Diabetes


subject: PUBCHEM.COMPOUND:45382195

object_name: diabetes mellitus


subject: UMLS:C0076616

subject_name: Thymosin beta-4


subject: UMLS:C0076616


subject: UMLS:C0076616


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Meniere disease


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Inflammatory abnormality of the eye


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:16349

subject_name: Citrulline

object_name: infectious disease


subject: CHEBI:16349

object_name: Infection


subject: CHEBI:16349

object_name: Infection of musculoskeletal system


subject: CHEBI:27306

subject_name: vitamin B6

object_name: primary hyperoxaluria type 1


subject: CHEBI:137262

subject_name: Leu-Asn-Ser

object_name: malnutrition


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UMLS:C4301616

subject_name: fluoroestradiol (18F)

object_name: uterine cancer


subject: UMLS:C4301616

object_name: tumor of uterus


subject: UMLS:C5439626

subject_name: Fluoroestradiol f 18, diagnostic, 1 millicurie


subject: UMLS:C5439626


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965